April 17th 2025
Elinzanetant significantly reduced the frequency and severity of vasomotor symptoms, known as hot flashes, compared with placebo across body mass index (BMI) and smoking status subgroups.
Tiara Green: Closing Geographic Disparities With Personalized Health Care
August 7th 2024Accessia Health works with advocacy groups to understand specific needs, such as travel assistance, affordable care, and diagnostic testing, ensuring a personalized and human-centered approach to health equity.
Watch
Access to Novel DMD Therapies Remains Challenging Despite Regulatory Approvals
August 5th 2024Aravindhan Veerapandiyan, MD, of the Division of Pediatric Neurology at the University of Arkansas for Medical Sciences, discussed the Duchenne muscular dystrophy (DMD) therapy landscape and barriers to treatment access.
Read More
Telehealth Availability for Mental Health Care Declined After COVID-19 Public Health Emergency
July 31st 2024Researchers analyzed the availability of telehealth services at mental health treatment facilities across the US before and after the end of the COVID-19 public health emergency through a national secret shopper analysis.
Read More
Early Treatment May Help Prevent PAH in High-Risk Patients
July 31st 2024New data from the single-center, open-label extension EDITA-ON study suggest that early treatment for pulmonary arterial hypertension (PAH) could benefit patients with systemic sclerosis and early pulmonary vascular disease.
Read More
Significant Pulmonary, Upper Limb Function Declines in Ambulatory Patients With DMD
July 27th 2024Trials of Duchenne muscular dystrophy (DMD) treatments targeting declining lung or upper limb function, which are typically limited to nonambulatory patients, could also include ambulatory patients, according to the study's findings
Read More
Potential Biomarkers Predict Disease Severity and Treatment Response in SMA
July 26th 2024Results from a single-center, observational, prospective study suggested that inflammatory markers could predict disease severity and treatment efficacy for patients with spinal muscular atrophy (SMA).
Read More
Tiara Green Calls for Comprehensive Support for Rare and Chronic Diseases
July 25th 2024Health care inequity is costing the United States billions of dollars without providing quality outcomes for patients with rare and chronic diseases, Tiara Green, MSEd, president of Accessia Health, tells The American Journal of Managed Care.
Watch
Efanesoctocog Alfa Prophylaxis Promising for Pediatric Severe Hemophilia A
July 25th 2024The phase 3, international, open-label, single-group XTEND-Kids study concluded that children with severe hemophilia A younger than 12 years benefited from treatment with efanesoctocog alfa prophylaxis.
Read More
Dr Mark Bleackley Addresses Lack of Pharmacotherapies in OSA, Need for IHL-42X
July 22nd 2024Mark Bleackley, PhD, chief scientific officer of Incannex, discusses in further detail the need for a pharmacotherapy like IHL-42X in obstructive sleep apnea (OSA) and the medication's underlying mechanisms.
Read More
Response to Immunotherapy Linked With Improved Liver Function in Advanced HCC
July 22nd 2024Although the amount of real-world evidence demonstrating the safety and efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma (HCC) has been growing, data on liver function evolution as a prognostic factor for overall survival are lacking.
Read More
Understanding Coverage, Financing, and Future Trends of Gene Therapy in Employer Health Plans
July 21st 2024The Greater Philadelphia Business Coalition on Health webinar series provided an in-depth framework for the advantages of including cell and gene therapy coverage in employer health plans, as well as the challenges brought by manufacturing complexities and the need to address accessibility to treatment.
Read More
Dr Rachel Dalthorp Details Her Approach to Closing Gaps in Postpartum Mental Health Care
July 21st 2024Screening for postpartum depression while patients are pregnant is a crucial step to ensuring they get access to treatment if they need it postpartum, according to Rachel Dalthorp, MD, of LifeStance Health.
Watch
New Report Shows Worsening Health Outcomes for Women in States With Abortion Bans
July 18th 2024The Commonwealth Fund scorecard ranks Mississippi, Texas, Nevada, and Oklahoma among the poorest-performing states overall for women’s health care access, quality, and outcomes, while Massachusetts, Vermont, and Rhode Island rank at the top.
Read More